Panacea Biotec Limited (PANACEABIO.NS)

133.10 -3.95 (-2.88%) At close: 03:29PM IST

Panacea Biotec Limited

B-1 Extension/G-3
Mohan Co-operative Industrial Estate Mathura Road
New Delhi 110044
India
91 11 4167 9000
https://www.panaceabiotec.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 1,794

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Rajesh Jain Ph.D.	Chairman of the Board & MD	8.24M	N/A	1964
Mr. Sandeep Jain	Joint MD & Executive Director	7.56M	N/A	1966
Mr. Devender Gupta	CFO & Head of Information Technology	N/A	N/A	1973
Dr. Khalid Al Syed	Chief Scientific Officer	N/A	N/A	1975
Mr. Vinod Goel	Group CFO, Head of Legal, Company Secretary & Compliance Officer	N/A	N/A	1965
Mr. Ankesh Jain	Director of Sales & Marketing and Whole-Time Director	2.93M	N/A	1988
Mr. Parmanand Das Karan	Sr. Vice President - Business Development & Corporate Affairs	N/A	N/A	N/A
Mr. Rajneesh Chatrath	Vice President of Corporate Quality Assurance	N/A	N/A	1968
Mr. Lalitendu Mohanty	VP of Clinical Research, Bio-analytical Lab	N/A	N/A	1967
Dr. Rajeeva Kumar Mangalum	Chief Operating Officer	N/A	N/A	1961

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceutical formulations and vaccines in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, and gastro-intestinal care; and pneumococcal vaccine, dengue tetravalent vaccine, typhoid conjugate vaccine, and universal flu vaccine. It also exports its products to approximately 36 countries, including the United States, Germany, Russian Federation, Turkey, Bosnia, Tanzania, Kenya, Serbia, Vietnam, Philippines, Sri Lanka, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. The company was incorporated in 1984 and is based in New Delhi, India.

Corporate governance

Panacea Biotec Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.